Summit Healthcare Acquisition Corp. (SMIH) Research
Summit Healthcare Acquisition Corp. presently conducts no substantial business operations. Its primary objective is to execute a strategic business combination—potentially a merger, share exchange, asset acquisition, stock purchase, corporate reorganization, or a similar transaction—with one or more distinct businesses or entities. The company was established in 2020 and maintains its headquarters in Central, Hong Kong.
Market snapshot
- Symbol
- SMIH
- Price
- $13.00
- Day change
- -0.38%
- Market cap
- $334.8M
- P/E ratio
- -408.70x
- 52-week range
- 9.2-18.4399
- Sector
- Financial Services
- Industry
- Shell Companies
Peer companies
- Tribe Capital Growth Corp I (ATVC)
- dMY Technology Group, Inc. VI (DMYS)
- Forbion European Acquisition Corp. (FRBN)
- The Growth for Good Acquisition Corporation (GFGD)
- Healthwell Acquisition Corp. I (HWEL)
- Horizon Acquisition Corporation II (HZON)
- MELI Kaszek Pioneer Corp (MEKA)
- Rocket Internet Growth Opportunities Corp. (RKTA)
Recent insider activity
- Tan Bo — D-Return (5300000 shares) on 2023-03-16
- Tan Bo — D-Return (6000000 shares) on 2023-03-16
- Bai Tao — D-Return (25000 shares) on 2023-03-16
- Folinsbee Thomas — D-Return (25000 shares) on 2023-03-16
- Summit Healthcare Acquisition Sponsor LLC — D-Return (6000000 shares) on 2023-03-16
Open Summit Healthcare Acquisition Corp. (SMIH) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.